| Mrs Nita G Harris, MD | |
|
2222 N Nevada Ave Ste 4007, Colorado Springs, CO 80907-6863 | |
| (719) 776-8500 | |
| (719) 776-4595 |
| Full Name | Mrs Nita G Harris |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 37 Years |
| Location | 2222 N Nevada Ave Ste 4007, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386680726 | NPI | - | NPPES |
| 31202870 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 41223 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Heart Of The Rockies Regional Medical Center | Salida, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cs Cardiology Newco Llc | 2365805736 | 40 |
| Catholic Health Initiatives Colorado | 8022927342 | 998 |
News Archive
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.
Activaero GmbH, the therapeutic area specialist for respiratory diseases focusing on novel, pharmacoeconomically meaningful treatment solutions, today announced that its partner Ablynx NV has initiated additional Phase I studies with its anti-RSV Nanobody ALX-0171 using Activaero's FAVORITE inhalation approach.
The Ontario Medical Association (OMA) said today that physicians across the province are showing keen interest in the new provincially funded program to transition physician offices from paper-based records to electronic medical records.
US physicians have raised concerns over the diagnosis and treatment of gastroesophageal reflux disease in small children, especially among infants for whom regurgitation is normal and likely to resolve with conservative treatment
› Verified 9 days ago
| Entity Name | Lutheran Hospital Association Of The San Luis Valley |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235181744 PECOS PAC ID: 4789589094 Enrollment ID: O20031201000318 |
News Archive
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.
Activaero GmbH, the therapeutic area specialist for respiratory diseases focusing on novel, pharmacoeconomically meaningful treatment solutions, today announced that its partner Ablynx NV has initiated additional Phase I studies with its anti-RSV Nanobody ALX-0171 using Activaero's FAVORITE inhalation approach.
The Ontario Medical Association (OMA) said today that physicians across the province are showing keen interest in the new provincially funded program to transition physician offices from paper-based records to electronic medical records.
US physicians have raised concerns over the diagnosis and treatment of gastroesophageal reflux disease in small children, especially among infants for whom regurgitation is normal and likely to resolve with conservative treatment
› Verified 9 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.
Activaero GmbH, the therapeutic area specialist for respiratory diseases focusing on novel, pharmacoeconomically meaningful treatment solutions, today announced that its partner Ablynx NV has initiated additional Phase I studies with its anti-RSV Nanobody ALX-0171 using Activaero's FAVORITE inhalation approach.
The Ontario Medical Association (OMA) said today that physicians across the province are showing keen interest in the new provincially funded program to transition physician offices from paper-based records to electronic medical records.
US physicians have raised concerns over the diagnosis and treatment of gastroesophageal reflux disease in small children, especially among infants for whom regurgitation is normal and likely to resolve with conservative treatment
› Verified 9 days ago
| Entity Name | Optumcare Colorado Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407252828 PECOS PAC ID: 2769706431 Enrollment ID: O20150129000413 |
News Archive
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.
Activaero GmbH, the therapeutic area specialist for respiratory diseases focusing on novel, pharmacoeconomically meaningful treatment solutions, today announced that its partner Ablynx NV has initiated additional Phase I studies with its anti-RSV Nanobody ALX-0171 using Activaero's FAVORITE inhalation approach.
The Ontario Medical Association (OMA) said today that physicians across the province are showing keen interest in the new provincially funded program to transition physician offices from paper-based records to electronic medical records.
US physicians have raised concerns over the diagnosis and treatment of gastroesophageal reflux disease in small children, especially among infants for whom regurgitation is normal and likely to resolve with conservative treatment
› Verified 9 days ago
| Entity Name | Cs Cardiology Newco Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750085445 PECOS PAC ID: 2365805736 Enrollment ID: O20230901000086 |
News Archive
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.
Activaero GmbH, the therapeutic area specialist for respiratory diseases focusing on novel, pharmacoeconomically meaningful treatment solutions, today announced that its partner Ablynx NV has initiated additional Phase I studies with its anti-RSV Nanobody ALX-0171 using Activaero's FAVORITE inhalation approach.
The Ontario Medical Association (OMA) said today that physicians across the province are showing keen interest in the new provincially funded program to transition physician offices from paper-based records to electronic medical records.
US physicians have raised concerns over the diagnosis and treatment of gastroesophageal reflux disease in small children, especially among infants for whom regurgitation is normal and likely to resolve with conservative treatment
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Nita G Harris, MD 2 South Cascade Avenue, Suite 140, Colorado Spring, CO 80903-1604 Ph: (719) 538-2900 | Mrs Nita G Harris, MD 2222 N Nevada Ave Ste 4007, Colorado Springs, CO 80907-6863 Ph: (719) 776-8500 |
News Archive
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its recently launched pain reliever, Cobroxin, was selected as the "Best New Product" at the Efficient Collaborative Retail Marketing (ECRM) Conference. Cobroxin was chosen as the award recipient by conference attendees, including several of the leading national retailers.
Activaero GmbH, the therapeutic area specialist for respiratory diseases focusing on novel, pharmacoeconomically meaningful treatment solutions, today announced that its partner Ablynx NV has initiated additional Phase I studies with its anti-RSV Nanobody ALX-0171 using Activaero's FAVORITE inhalation approach.
The Ontario Medical Association (OMA) said today that physicians across the province are showing keen interest in the new provincially funded program to transition physician offices from paper-based records to electronic medical records.
US physicians have raised concerns over the diagnosis and treatment of gastroesophageal reflux disease in small children, especially among infants for whom regurgitation is normal and likely to resolve with conservative treatment
› Verified 9 days ago
Michael Judd Burkholz, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2940 N Circle Dr, Colorado Springs, CO 80909 Phone: 719-635-7321 Fax: 719-635-2510 | |
Mrs. Rachel Elizabeth Black, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2222 N Nevada Ave Ste 4004, Colorado Springs, CO 80907 Phone: 719-471-7064 | |
William A Munson, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 325 E Fontanero St, Colorado Springs Endocrine Clinic Pc, Colorado Springs, CO 80907 Phone: 719-636-3829 Fax: 719-636-1387 | |
Barbara E Johnston, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 175 S Union Blvd Ste 350, Colorado Springs, CO 80910 Phone: 719-633-5515 Fax: 719-365-1307 | |
Dr. Raymond L. Wahl, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2502 E Pikes Peak Ave, Colorado Springs, CO 80909 Phone: 719-630-6440 Fax: 719-228-6603 | |
Dr. Duane Ryan Spaulding, M.D., F.A.C.P. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 6722 Northface Ln, Colorado Springs, CO 80919 Phone: 719-590-9338 | |
Dr. Wendy Marie Bamberg, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 301 S Union Blvd, Colorado Springs, CO 80910 Phone: 719-578-3199 |